Current Projects

Our projects advance the understanding of psoriasis, improve patient care and support the next generation of psoriasis leaders.

Disease Severity ClassificationDefining disease severity classification

Global Psoriasis AtlasComprehensive global database on psoriasis

Latin America Working GroupImproving care for patients in Latin America

PsoProtect Registry Partnership An international registry developed to report outcomes of COVID-19 in psoriasis patients

Telemedicine Improving access to effective treatments, timely diagnosis and optimal care

Latest news

Video Series on IPC’s Psoriasis Severity Reclassification

March 30, 2021

Learn how psoriasis severity is currently measured and why a change is necessary, how IPC organized the Delphi process that was used to redefine severity classification, implications and effects the output has on psoriasis treatment providers and psoriasis patients, and ultimately how patients will benefit from this endeavor.

Janssen Phase-3 TREMFYA® Clinical Trial

March 29, 2021

Janssen Pharmaceutical Companies of Johnson & Johnson published the long-term data of the third phase of the DISCOVER-2a study.

Sun Pharma Phase-3 ILUMYA® Clinical Trial

March 28, 2021

Sun Pharmaceutical Industries Inc. announces results from their five-year Phase-3 efficacy and safety clinical trial for ILUMYA®(tildrakizumab-asmn) based on a pooled analysis of the ReSURFACE 1 and ReSURFACE 2 extension.

Update on PsoProtect Registry Data

March 17, 2021

Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1002 cases.

More News

Current Projects

COVID-19 Psoriasis Resource Center

Latest news

Advancing Knowledge. Enhancing Care.